These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23256456)

  • 1. Alterations in serum MMP and TIMP concentrations following chronic heroin abuse.
    Kovatsi L; Batzios S; Nikolaou K; Fragou D; Njau S; Tsatsakis A; Karakiulakis G; Papakonstantinou E
    Toxicol Mech Methods; 2013 Jun; 23(5):377-81. PubMed ID: 23256456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.
    Mühl D; Nagy B; Woth G; Falusi B; Bogár L; Weber G; Lantos J
    J Crit Care; 2011 Dec; 26(6):550-5. PubMed ID: 21530151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases.
    Lakatos G; Hritz I; Varga MZ; Juhász M; Miheller P; Cierny G; Tulassay Z; Herszényi L
    Dig Dis; 2012; 30(3):289-95. PubMed ID: 22722554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors.
    Latronico T; Mascia C; Pati I; Zuccala P; Mengoni F; Marocco R; Tieghi T; Belvisi V; Lichtner M; Vullo V; Mastroianni CM; Liuzzi GM
    Int J Mol Sci; 2016 Mar; 17(4):455. PubMed ID: 27023536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
    Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
    J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases in isolated hypercholesterolemia.
    Malik J; Stulc T; Ceska R
    Int Angiol; 2005 Sep; 24(3):300-3. PubMed ID: 16158043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity.
    Dietmann A; Helbok R; Lackner P; Issifou S; Lell B; Matsiegui PB; Reindl M; Schmutzhard E; Kremsner PG
    J Infect Dis; 2008 Jun; 197(11):1614-20. PubMed ID: 18700258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis.
    Tsai HC; Shi MH; Lee SS; Wann SR; Tai MH; Chen YS
    Clin Microbiol Infect; 2011 May; 17(5):780-4. PubMed ID: 21521415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum MMPs and TIMPs: may be predictors of breast carcinogenesis?
    Zagouri F; Sergentanis TN; Kalogera E; Provatopoulou X; Chrysikos D; Zografos E; Bletsa G; Flessas I; Papadimitriou CA; Zografos GC; Gounaris A
    Clin Chim Acta; 2011 Mar; 412(7-8):537-40. PubMed ID: 21130755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury.
    Zheng K; Li C; Shan X; Liu H; Fan W; Wang Z; Zheng P
    Neurol India; 2013; 61(6):606-9. PubMed ID: 24441327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis.
    Kathamuthu GR; Kumar NP; Moideen K; Nair D; Banurekha VV; Sridhar R; Baskaran D; Babu S
    Front Immunol; 2020; 11():419. PubMed ID: 32218787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum profiles of matrix metalloproteinases and their tissue inhibitors in long-term pulmonary complication induced by sulfur mustard: Sardasht-Iran Cohort Study (SICS).
    Kiani A; Mostafaie A; Shirazi FH; Ghazanfari T
    Int Immunopharmacol; 2013 Nov; 17(3):964-7. PubMed ID: 23370298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Matrix metalloproteinases and their tissue inhibitors in children and young adults on chronic hemodialysis--preliminary results].
    Musiał K; Makulska I; Zwolńska D
    Pol Merkur Lekarski; 2009 Apr; 26(154):290-3. PubMed ID: 19580190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
    Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
    Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum interleukin 6 (il-6A) concentration correlates with matrix metalloproteinases and their tissue inhibitors in rheumatoid arthritis].
    Klimiuk PA; Sierakowski S; Chwiećko J
    Pol Arch Med Wewn; 2003 Feb; 109(2):119-23. PubMed ID: 12879774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic regulation of angiogenesis and matrix degradation in bone regeneration--distraction osteogenesis compared to rigid fracture healing.
    Weiss S; Zimmermann G; Baumgart R; Kasten P; Bidlingmaier M; Henle P
    Bone; 2005 Dec; 37(6):781-90. PubMed ID: 16202678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.